Terms: = Head and neck cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Treatment
98 results:
1. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
Liu Y; Yin Z; Wang Y; Chen H
Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
[TBL] [Abstract] [Full Text] [Related]
2. Vemurafenib activates the sonic hedgehog pathway and promotes thyroid cancer stem cell self-renewal.
Lu Y; Zhao Y; Liu P; Xu X
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37643458
[TBL] [Abstract] [Full Text] [Related]
3. A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, her3/4 mutation or KRAS mutation.
Piha-Paul SA; Tseng C; Tran HT; Gao M; Karp DD; Subbiah V; Tsimberidou AM; Kawedia JD; Fu S; Pant S; Yap TA; Morris VK; Kee BK; Blum Murphy M; Lim J; Meric-Bernstam F
Cancer Chemother Pharmacol; 2023 Aug; 92(2):107-118. PubMed ID: 37314501
[TBL] [Abstract] [Full Text] [Related]
4. Disulfiram/Cu Kills and Sensitizes
Xie J; Liu J; Zhao M; Li X; Wang Y; Zhao Y; Cao H; Ji M; Chen M; Hou P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834830
[No Abstract] [Full Text] [Related]
5. Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules.
Mao L; Zheng C; Ou S; He Y; Liao C; Deng G
Front Endocrinol (Lausanne); 2022; 13():1067390. PubMed ID: 36619577
[TBL] [Abstract] [Full Text] [Related]
6. Response to Neoadjuvant Targeted Therapy in Operable head and neck cancer Confers Survival Benefit.
Mascarella MA; Olonisakin TF; Rumde P; Vendra V; Nance MA; Kim S; Kubik MW; Sridharan SS; Ferris RL; Fenton MJ; Clayburgh DR; Ohr JP; Joyce SC; Sen M; Herman JG; Grandis JR; Zandberg DP; Duvvuri U
Clin Cancer Res; 2023 Feb; 29(4):723-730. PubMed ID: 36595540
[TBL] [Abstract] [Full Text] [Related]
7. Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
Garcia-Rendueles MER; Krishnamoorthy G; Saqcena M; Acuña-Ruiz A; Revilla G; de Stanchina E; Knauf JA; Lester R; Xu B; Ghossein RA; Fagin JA
Mol Cancer; 2022 Dec; 21(1):213. PubMed ID: 36476495
[TBL] [Abstract] [Full Text] [Related]
8. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.
Viktorsson K; Hååg P; Shah CH; Franzén B; Arapi V; Holmsten K; Sandström P; Lewensohn R; Ullén A
Mol Oncol; 2022 Oct; 16(20):3620-3641. PubMed ID: 35838333
[TBL] [Abstract] [Full Text] [Related]
9. Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review.
Blangé D; Stroes CI; Derks S; Bijlsma MF; van Laarhoven HWM
Cancer Treat Rev; 2022 Jul; 108():102418. PubMed ID: 35689885
[TBL] [Abstract] [Full Text] [Related]
10. Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
Yang Z; Liao J; Schumaker L; Carter-Cooper B; Lapidus RG; Fan X; Gaykalova DA; Mehra R; Cullen KJ; Dan H
Oral Oncol; 2022 Aug; 131():105939. PubMed ID: 35667295
[TBL] [Abstract] [Full Text] [Related]
11. AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
Iida M; McDaniel NK; Kostecki KL; Welke NB; Kranjac CA; Liu P; Longhurst C; Bruce JY; Hong S; Salgia R; Wheeler DL
BMC Cancer; 2022 Apr; 22(1):447. PubMed ID: 35461210
[TBL] [Abstract] [Full Text] [Related]
12. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
13. Enhancing Radioiodine Incorporation in
Tchekmedyian V; Dunn L; Sherman E; Baxi SS; Grewal RK; Larson SM; Pentlow KS; Haque S; Tuttle RM; Sabra MM; Fish S; Boucai L; Walters J; Ghossein RA; Seshan VE; Knauf JA; Pfister DG; Fagin JA; Ho AL
Thyroid; 2022 Mar; 32(3):273-282. PubMed ID: 35045748
[No Abstract] [Full Text] [Related]
14. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
15. A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Lee JH; Heo SG; Ahn BC; Hong MH; Cho BC; Lim SM; Kim HR
Cancer Med; 2021 Oct; 10(20):7012-7020. PubMed ID: 34528763
[TBL] [Abstract] [Full Text] [Related]
16. Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma.
Sumner W; Ray X; Sutton L; Rebibo D; Marincola F; Sanghvi P; Moiseenko V; Deichaite I
J Transl Med; 2021 May; 19(1):212. PubMed ID: 34001187
[TBL] [Abstract] [Full Text] [Related]
17. Disruption of the her3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.
Wang Z; Goto Y; Allevato MM; Wu VH; Saddawi-Konefka R; Gilardi M; Alvarado D; Yung BS; O'Farrell A; Molinolo AA; Duvvuri U; Grandis JR; Califano JA; Cohen EEW; Gutkind JS
Nat Commun; 2021 Apr; 12(1):2383. PubMed ID: 33888713
[TBL] [Abstract] [Full Text] [Related]
18. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of erbb3/EGFR-ERK signaling resulting in unfavorable patient survival.
Peng LX; Wang MD; Xie P; Yang JP; Sun R; Zheng LS; Mei Y; Meng DF; Peng XS; Lang YH; Qiang YY; Li CZ; Xu L; Liu ZJ; Guo LL; Xie DH; Shu DT; Lin ST; Luo FF; Huang BJ; Qian CN
Cancer Lett; 2021 Feb; 498():165-177. PubMed ID: 33152401
[TBL] [Abstract] [Full Text] [Related]
19. Combinatorial approaches targeting the EGFR family and c-Met in SCCHN.
Wang D; Lu Y; Nannapaneni S; Griffith CC; Steuer C; Qian G; Wang X; Chen Z; Patel M; El-Deiry M; Shin DM; He X; Chen ZG; Saba NF
Oral Oncol; 2021 Jan; 112():105074. PubMed ID: 33142224
[TBL] [Abstract] [Full Text] [Related]
20. Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for head and neck Squamous Cell Carcinoma.
Wu ZH; Yun-Tang ; Cheng Q
Cell Transplant; 2020; 29():963689720929308. PubMed ID: 32452220
[TBL] [Abstract] [Full Text] [Related]
[Next]
